1. Home
  2. NCZ vs EMBC Comparison

NCZ vs EMBC Comparison

Compare NCZ & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Convertible & Income Fund II of Beneficial Interest

NCZ

Virtus Convertible & Income Fund II of Beneficial Interest

N/A

Current Price

$14.80

Market Cap

288.7M

Sector

Finance

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

N/A

Current Price

$5.24

Market Cap

279.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NCZ
EMBC
Founded
2003
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.7M
279.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NCZ
EMBC
Price
$14.80
$5.24
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
39.7K
1.2M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
12.16%
6.88%
EPS Growth
N/A
20.90
EPS
N/A
1.03
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.94
Revenue Growth
N/A
N/A
52 Week Low
$12.95
$2.77
52 Week High
$16.17
$15.55

Technical Indicators

Market Signals
Indicator
NCZ
EMBC
Relative Strength Index (RSI) 31.76 52.77
Support Level $14.78 $4.80
Resistance Level $14.86 $5.77
Average True Range (ATR) 0.25 0.27
MACD -0.06 -0.09
Stochastic Oscillator 12.15 26.13

Price Performance

Historical Comparison
NCZ
EMBC

About NCZ Virtus Convertible & Income Fund II of Beneficial Interest

Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. The investment objective of the company is to provide total return through a combination of current income, current gains and long-term capital appreciation. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas, and consumable fuels and others.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: